Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-24 @ 11:16 PM
NCT ID:
NCT02635256
Eligibility Criteria:
Inclusion Criteria:
* Localised, histopathologically confirmed Prostate Cancer (cT1-3 N0 M0)
* Gleason-grade ≤7
* Guideline-based staging
* Age ≥ 60 years
* PSA \< 15 ng/ml
* Volume of the prostate \<80 cm³
* IPSS-Score ≤12
* Written informed consent
Exclusion Criteria:
* History of prior pelvic radiotherapy
* Contraindication to MRI or Fiducial marker implantation (e.g. allergy to gold),
* Immunosuppressive therapy
* Relevant comorbidity thought to adversely affect treatment compliance,
* Legal incapacity or lack of informed consent
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
60 Years
Study:
NCT02635256
Study Brief:
Protocol Section:
NCT02635256